CEO · Founder, Cartherics
| Role | Organisation | Sources |
|---|---|---|
| CEO · Founder | Cartherics | Forbes Australia |
| Emeritus Professor (former) | Monash University | Forbes Australia |
Stories naming Professor Alan Trounson. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Profile of Melbourne biotech Cartherics, which is extending its off-the-shelf cell therapy platform from ovarian cancer to endometriosis; its CEO outlines a capital raise in progress and 2026 clinical trial plans.
A Melbourne biotechnology firm developing a CAR-NK cell therapy for ovarian cancer has completed a fifteen-million-dollar raise to fund its first trial in humans and work toward other cancers.